Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
April 13th 2023At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient population.
Read More
Dr Sashi Naidu: Financial Concerns Are a Constant Challenge in Community Oncology
April 9th 2023Sashi Naidu, MD, is director of research at Carolina Blood and Cancer Care Associates, where the No One Left Alone (NOLA) initiative is working to break down cancer health disparities among its patients and prevent care fragmentation.
Read More
Biosimilars Are Mighty, Can Help Alleviate Drug Spend Cost Burden
April 8th 2023With the global market for biologics estimated at $382 billion just last year, and a projected global drug spend of close to $1.5 trillion by 2027, the landscape is ripe for biosimilars to help decrease the health care system’s cost burden.
Read More
Dr David Penberthy: Technology Is a Great Leveler for Health Equity
April 7th 2023David R. Penberthy, MD, MBA, 2022-2023 Association of Community Cancer Centers president, addresses technological advancements made during his presidency and how community oncology is working to ensure gains in health equity continue moving forward.
Read More
A Conversation on the Past, Present, and Future of Public Health: NPHW 2023
April 3rd 2023For National Public Health Week this year, we sat down with Kristen Krause, PhD, MPH, instructor in the Department of Urban-Global Public Health and deputy director, Center for Health, Identity, Behavior and Prevention Studies, Rutgers School of Public Health.
Read More
Dr Olalekan Ajayi: AI Models Are Only as Good as Their Data
April 2nd 2023In this interview from the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Center Business Summit, Olalekan Ajayi, PharmD, MBA, ACCC president, addresses the use of artificial intelligence (AI) in health care equity and why data integrity is just as important as the models used with the data.
Read More
Dr David Eagle: Health Equity Involves More Than Medical Care
April 2nd 2023Close to 80% of what influences how long someone is going to live is where and how they live, and we need to pay more attention to that or we’re not paying attention to everything that affects their lives, explained David A. Eagle, MD, of New York Cancer & Blood Specialists.
Read More
Prurigo Nodularis Improves Following Treatment With Dupilumab
March 30th 2023Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the monoclonal antibody for the chronic inflammatory skin condition.
Read More
CVD Outcomes Investigation Highlights Need for More, Better Data on SDOH
March 29th 2023This study of the public health landscape in New York City investigated the interplay between social determinants of health (SDOH), chronic health conditions, and inequities in social factors, with a focus on cardiovascular disease (CVD).
Read More
Is Dose Rounding the Answer to Cancer Drug Waste?
March 24th 2023Implementing a strategy that focuses on dose rounding for chemotherapies can have a 3-fold impact of decreasing drug costs, minimizing drug waste, and improving treatment efficiency. This strategy and its benefits were explored in a session on day 2 of AMCP 2023.
Read More
Where Challenges Lie in Health Disparities, Opportunities Exist for Health Equity
March 23rd 2023In this session at AMCP 2023, speakers broke down the challenges many managed care organizations face when wanting to collect detailed data on health disparities and proffered potential strategies that may help to facilitate gathering these data to address inequitable health care access.
Read More
Experts Call for a More Patient-Focused Approach to Prior Authorization
March 23rd 2023On the first full day of conference activity at AMCP 2023, a morning session examined prior authorization (PA) through a lens of refining the current process and the potential role of clinical trial data in PA criteria.
Read More
There Is Something for Everyone to Do to Improve Health Equity, Says Oncology Consultants’ Wagner
March 22nd 2023Many people believe health equity is such a big issue that there is not much an individual practice can do to address it, explained Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy, Oncology Consultants of Houston.
Read More
Pediatric Patients See Benefit in Short-, Long-term Treatment for AD
March 22nd 2023Data from the LIBERTY AD PRESCHOOL trial, and its ongoing open-label extension analysis show that dupilumab is safe and clinically effective, and can lead to statistically significant symptom improvement among patients aged 6 months to 17 years who have moderate to severe atopic dermatitis (AD).
Read More
Dr Tochi Okwuosa: Baseline Risk Assessment of Heart Function Necessary in Cancer Care
March 21st 2023Baseline risk assessment that includes prior treatment history for cancer, prior cardiovascular events, and markers for potential heart damage are all important, emphasizes Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center in Chicago.
Read More
Patient Outcomes Improve on Several Fronts Following Treatment for Prurigo Nodularis
March 20th 2023Subanalyses of data from the LIBERTY PN-PRIME and LIBERTY PN-PRIME2 studies illustrate how dupilumab for prurigo nodularis can better patient outcomes, including quality of life and symptom burden.
Read More
Patients With AD May Have Greater Risk of Certain Malignancies
March 17th 2023Investigators of this study noted the need for more data on risks of malignancies among patients who have atopic dermatitis (AD), with the chronic skin condition already having significant associations with nonmelanoma skin cancer, lymphoma, keratinocyte carcinoma, and pancreatic and kidney cancers.
Read More
Trio of Scales Deemed Valid, Reliable for Use in Prurigo Nodularis
March 16th 2023The Skin Pain Numeric Rating Scale, Worst-Itch Numeric Rating Scale, and Dermatology Life Quality Index were evaluated for their content validity, fit-for-purpose, and psychometric and measurement properties among patients with the chronic skin disease being treated with dupilumab.
Read More
Dr David Eagle on Celebrating 20 Years of COA at This Year’s Meeting
March 15th 2023In this preview of the 2023 Community Oncology Conference, past president of the Community Oncology Alliance, David Eagle, MD, of New York Cancer & Blood Specialists, discusses what has him excited for this year's meeting, both sessions and speakers.
Read More
Highlands Oncology Group’s Jeff Hunnicutt Discusses Risk Under the EOM
March 10th 2023Jeff Hunnicutt, CEO of Highlands Oncology Group, explains the 2 risk options provided under the Enhancing Oncology Model (EOM) and why the mandatory downside risk might give pause to practices that saw some success in the Oncology Care Model.
Read More
Dr Sigrun Hallmeyer Discusses Use of Precision Medicine in the First-line Setting
March 10th 2023As scientists are identifying molecular alterations in patients with later-stage cancers that may be targets in earlier-stage disease, next-generation sequencing is being utilized more in the first-line setting, noted Sigrun Hallmeyer, MD, medical oncologist with Advocate Health.
Read More
Dr Kevin Davies: There Is Great Potential for CRISPR in Genetic Diseases and Cancers
March 9th 2023Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, discusses how CRISPR has evolved from the initial discovery of the double helix to now, with the technology holding great promise for both genetic diseases and cancers.
Read More
Dr Andre Harvin: Pharmacists Play a Critical Role in Oncology Care
March 9th 2023Andre Harvin, PharmD, MS, MBA, Cone Health Cancer Center, discusses the vital role of pharmacists in oncology: how they use data to streamline patient visits, work to facilitate patient access to biosimilars, and advocate for their patients.
Read More